Skip to main content
Premium Trial:

Request an Annual Quote

Affymetrix Gets NIAID Grant to develop Biodefense Microarray

NEW YORK, Oct. 20 (GenomeWeb News) - Affymetrix said today that it will develop a microarray for detection of bacterial and viral biological threats, such as anthrax and plague, based on a $2.1 million grant from the National Institute of Allergy and Infectious Diseases.

 

The Santa Clara, Calif.-based firm expects to have a GeneChip prototype array available in three months, and a multi-pathogen array commercially available in three years. Affymetrix said the resequencing technology that will be used in the array will be identical to that used in its SARS and smallpox virus arrays developed earlier this year.

The Scan

Two J&J Doses

Johnson & Johnson says two doses of its SARS-CoV-2 vaccine provides increased protection against symptomatic COVID-19, CNN reports.

Pfizer-BioNTech Vaccine Response in Kids

The Pfizer-BioNTech SARS-CoV-2 vaccine in a lower-dose format appears to generate an immune response among children, according to the Washington Post.

Chicken Changes to Prevent Disease

The Guardian writes that researchers are looking at gene editing chickens to help prevent future pandemics.

PNAS Papers on Siberian Dog Ancestry, Insect Reproduction, Hippocampal Neurogenesis

In PNAS this week: ancestry and admixture among Siberian dogs, hormone role in fruit fly reproduction, and more.